02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(1982): Gall H+, Derm Beruf Umwelt (German) 30, 55 (from<br />

antiperspirant)<br />

Diaphoresis (>10%)<br />

Exanthems<br />

Rash (sic) (10%)<br />

Mucosal<br />

Sialopenia<br />

Xerostomia (>10%)<br />

(1993): Ahmed T+, Bone Marrow Transplant 12(2), 131<br />

(1986): Hassan M+, Am J Gastroenterol 81(5), 334<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

PROPOFOL<br />

Trade name: Diprivan (AstraZeneca)<br />

Indications: Induction <strong>and</strong> maintenance of anesthesia<br />

Category: Anesthetic, general<br />

Half-life: initial: 40 minutes; terminal: 3 days<br />

Clinically important, potentially hazardous interactions<br />

with: zinc<br />

Reactions<br />

Skin<br />

Allergic reactions (sic)<br />

(1988): Jamieson V+, Anaesthesia 43, 70<br />

Edema (1%)<br />

(1987): Coursange F+, Ann Fr Anesth Reanim (French) 6, 258<br />

Rash (sic) (5%)<br />

Raynaud’s phenomenon<br />

(1999): Gilston A, Anaesthesia 54, 307<br />

Urticaria<br />

(1988): Aitken HA, Anaesthesia 43, 170<br />

(1987): Coursange F+, Ann Fr Anesth Reanim (French) 6, 258<br />

Mucosal<br />

Sialorrhea (>1%)<br />

Xerostomia (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!